Navigation Links
Study finds cancer is the second most frequent cause of death in individuals with schizophrenia
Date:6/21/2009

People with schizophrenia die from cancer four times as often as people in the general population. That was the conclusion of a new study published in the August 1, 2009 issue of CANCER, a peer-reviewed journal of the American Cancer Society. The study's results suggest that extra efforts should be made to improve cancer prevention and early detection in patients with schizophrenia.

Schizophrenia is associated with an increased incidence of premature death, in part due to a high rate of suicide among individuals with the disease. However, suicide alone does not account for the shortened life expectancy seen in schizophrenia patients. Some studies have indicated that cancer mortality may play a role, but other data suggest that cancer rates are actually lower among individuals with schizophrenia compared with the general population.

To more precisely determine the prevalence of cancer in patients with schizophrenia, Prof. Frdric Limosin of the University of Reims, Robert Debr Hospital, in Reims, France and colleagues prospectively studied 3,470 patients with schizophrenia and tracked cancer incidence beginning in 1993. The investigators also sought to identify characteristics that might help predict which schizophrenic patients are likely to develop cancer.

The researchers found that 476 (14%) patients died during the eleven years of the study, a death rate was nearly four-fold higher than in the general population. Seventy-four patients died of cancer, making it the second most frequent cause of death behind suicide. In men with schizophrenia, the risk of death due to lung cancer was significantly higher than that in the general population, but the risk of overall cancer death was not significantly higher. In women, the risk of overall mortality was significantly higher than among the general population. The proportion of patients who were smokers was significantly higher in the study population than in the general population (56.3 vs. 33.0%). In female schizophrenic patients, the risk of death due to breast cancer was significantly higher than in the general population. The authors say possible explanations include is a delay in diagnosis due to patients paying less attention to symptoms; the difficulty for schizophrenic patients to benefit from optimum treatment; and less compliance to treatment.

Prof. Limosin and his collaborators noted that additional studies should further examine cancer rates in individuals with schizophrenia and should better define the characteristics of tumors that arise in these patients.


'/>"/>

Contact: Claire Greenwell
claire.greenwell@cancer.org
404-417-5883
American Cancer Society
Source:Eurekalert

Related medicine news :

1. Study finds that tobacco companies changed design of cigarettes without alerting smokers
2. Mayo researchers: Dramatic outcomes in prostate cancer study
3. Brain Imaging Study Sheds Light on Fibromyalgia
4. Arizona Heart Institute Enrolls First Patient in Anaconda(TM) Investigational Study for the Treatment of Abdominal Aortic Aneurysm
5. Study Finds Possible Genetic Indicator of Colorectal Cancer
6. $16.8 million study will breathe new life into cancer battle
7. Phase 1 Study Initiated with Micromet Anti-GM-CS Human Antibody MT203
8. Study supports validity of test that indicates widespread unconscious bias
9. Study finds reproductive health effects from low doses of bisphenol-A
10. New Study Finds 1 in 4 Multiple Sclerosis Patients With High Out-of-Pocket Costs Not Filling Prescriptions
11. Study Shows Increases in Working After 65 and Using Commercial Insurance
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/2/2016)... ... May 02, 2016 , ... ... announced a new Specialty Pharmacy Patient Satisfaction Award that will recognize specialty pharmacies ... quarterly results from Zitter Health Insights’ Specialty Pharmacy Patient Satisfaction Survey compiled throughout ...
(Date:5/2/2016)... ... May 02, 2016 , ... Visceral fat, also known as ... kidneys, liver and pancreas. If not properly addressed, visceral fat can lead to ... Medicine, Medical Oncology and Palliative Care, warns against the dangers of visceral fat. ...
(Date:5/2/2016)... (PRWEB) , ... May 02, ... ... researchers report that many commonly used prescription medications, including anxiolytics, painkillers, antidepressants ... mitigate these risks, Novus Medical Detox Center —a leading Florida-based drug ...
(Date:5/2/2016)... , ... May 02, 2016 , ... Pregnancy Awareness Month ... trying to conceive. , “If you are ready to have a baby, ... “My book, HealthChequesTM: Journal Babies is your Personal Conception & Pregnancy Organizer, written ...
(Date:5/2/2016)... , ... May 02, 2016 , ... ... and urgent care facilities designed to automate and improve the rapid diagnosis, triage ... it is demonstrating their platform, application, and mobile experience for the first time ...
Breaking Medicine News(10 mins):
(Date:4/28/2016)...   Acsis , a leading provider of supply ... research and advisory firm IDC has named it a ... Pharmaceutical Track and Trace Software 2016 Vendor Assessment (doc ... of the capabilities and business strategies of 10 vendors ... Logo - http://photos.prnewswire.com/prnh/20160427/360791LOGO ...
(Date:4/28/2016)... 2016 New market research ... a report that provides an overview of the ... by identifying new targets and MOAs to produce ... discussed in this H1 2016 Osteoarthritis Pipeline report ... Inc., Abiogen Pharma S.p.A., Ablynx NV, Achelios Therapeutics, ...
(Date:4/27/2016)... 2016   ... sur le trimestre, soutenu par une croissance de ... Croissance de +16% des ventes aux hôpitaux et ... Technologies (Euronext : MKEA, FR0010609263 ; OTCQX : MKEAY), inventeur de ... son chiffre d,affaires pour le premier trimestre clos ...
Breaking Medicine Technology: